News: Breast Cancer

Next Page »« Previous Page

Breast SPORE Grant Renewed Again

Wednesday, November 27th, 2013

Vanderbilt-Ingram Cancer Center’s Breast Specialized Program of Research Excellence (SPORE) has been awarded a third round of funding from the National Cancer Institute (NCI). The SPORE grant renewal will provide more than $11.3 million in funding support over the next five years for breast cancer research. “It is becoming uncommon for a cancer center to […]

Arteaga Leads New Cancer Initiatives

Friday, May 10th, 2013

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology, has been appointed to a leadership role of two newly created cancer research initiatives at Vanderbilt-Ingram Cancer Center. He has been named the founding director of the Center for Cancer Targeted Therapies (CCTT) and director of the Vanderbilt-Ingram Cancer Center Research Network (VICCRN). The CCTT […]

Arteaga Named AACR President-elect

Thursday, March 28th, 2013

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology at Vanderbilt University School of Medicine, has been chosen president-elect for 2013-2014 of the American Association for Cancer Research. Arteaga, who holds the Donna S. Hall Chair in Breast Cancer, also serves as associate director for clinical research and director of the Breast Cancer Research […]

LifeFlight goes pink for breast cancer awareness

Friday, September 28th, 2012

Nashville (Tenn.) – Vanderbilt LifeFlight is going pink during October to show its support for breast cancer awareness.LifeFlight medical crews will wear a special pink name badge on their flight suits and other staff will wear pink golf shirts. October is designated as National Breast Cancer Awareness Month, dedicated to raising awareness and educating individuals […]

Arteaga Named to Komen Scientific Advisory Board

Thursday, August 2nd, 2012

Carlos Arteaga, M.D., associate director for Clinical Research and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been named to the Scientific Advisory Board of the Susan G. Komen for the Cure Breast Cancer Research Foundation. Komen is the one of the largest nonprofit organizations dedicated to funding breast cancer research […]

Study Finds Stress Fuels Breast Cancer Metastasis to Bone

Wednesday, July 18th, 2012

Stress can promote breast cancer cell colonization of bone, Vanderbilt Center for Bone Biology investigators have discovered. The studies, reported July 17 in PLoS Biology, demonstrate in mice that activation of the sympathetic nervous system – the “fight-or-flight” response to stress – primes the bone environment for breast cancer cell metastasis. The researchers were able […]

Women Invited to Breast Screening Event

Friday, June 15th, 2012

The Vanderbilt Breast Center is hosting “Girls’ Day Out,” an event that offers women a chance to enjoy good food and pampering while they prepare for an annual breast cancer screening mammogram. The event is Saturday, June 23, from 10 a.m. to 1 p.m., at the Vanderbilt Breast Center, suite 25000 at Vanderbilt Health One […]

Patient Lauded for Clinical Trial Participation

Wednesday, June 13th, 2012

A breast cancer patient who has enrolled in two clinical research trials at Vanderbilt-Ingram Cancer Center was the only presenter to receive a standing ovation during a recent Stand Up To Cancer (SU2C) news briefing at the American Association for Cancer Research (AACR) annual meeting in Chicago. Jeanette Daniel, 51, a metastatic breast cancer patient, […]

New Breast Cancer Gene Expression Identified

Monday, June 11th, 2012

A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer. The study by lead author Justin Balko, Pharm.D., Ph.D., was published online June 10, 2012 […]

Postdoctoral Fellow of the Year

Wednesday, June 6th, 2012

Justin Balko, Pharm.D., Ph.D., was named Vanderbilt-Ingram Cancer Center’s Postdoctoral Fellow of the Year. He describes some of his breast cancer research pertaining to drug resistance and targeted therapeutics. He also notes the exceptional translational research environment that Vanderbilt provides. Balko is a researcher in the Carlos Arteaga lab.